Delivery Order SPE2DB24D2216-SPE2DB25FGMED

Award Date 11/18/24
Potential Completion Date 11/19/24
Potential Value $4.6K
Ultimate Awardee
Not listed
Federal Contract Vehicle
Set-Aside Type
No Set-Aside Used
Extent Competed
Full and Open Competition
Major Defense Program
Not listed
Pricing Type
Firm Fixed Price
Place of Performance
Conshohocken, PA 19428, USA
Solicitation Procedures
Negotiated Proposal / Quote
Number Of Offers Received
Not listed
Legislative Mandate
Not listed
National Interest Action
Not listed
Research Type
Not listed
Primary Consortia Member
Not listed
Similar Awards
The Defense Logistics Agency (DLA) awarded a delivery order contract worth $1,156.42 to Amerisourcebergen Drug Corp's Corporate Office division for the procurement of PROCTOFOAM-HC 1%-1% FOAM 10GM. This order is part of a larger Indefinite Delivery Contract (IDC) valued at up to $999,999,999.00 that Amerisourcebergen holds with DLA Troop Support Medical, which serves as the primary vehicle for the company to deliver a comprehensive range of pharmaceutical products and medical supplies to DLA...
The U.S. Defense Logistics Agency (DLA) has awarded a $1,889.04 firm fixed price delivery order contract to AmerisourceBergen Drug Corp, a major pharmaceutical distributor, for the supply of 4565185984 PROCTOFOAM-HC 1%-1% FOAM 10GM. This contract does not have a set-aside designation. The delivery order falls under AmerisourceBergen's larger Indefinite Delivery Contract (IDC) with the DLA Troop Support Medical, valued at up to $999,999,999 through December 2025, which enables the agency to...
The U.S. government's Defense Logistics Agency (DLA) Troop Support Medical awarded a delivery order contract to Amerisourcebergen Drug Corp, a major pharmaceutical distributor, to provide Proctofoam-HC 1%-1% foam in 10 gram packages. The $4,822.63 firm fixed-price contract has a completion date of July 9, 2024. Amerisourcebergen holds a larger $999,999,999 Indefinite Delivery Contract (IDC) with DLA Troop Support Medical to supply a comprehensive range of pharmaceutical and medical products to...
This is a federal contract award from the Defense Logistics Agency (DLA) Troop Support Medical to Amerisourcebergen Drug Corp, a major pharmaceutical distributor and healthcare solutions provider. The contract, valued at $1,444.13, is for the delivery of PROCTOFOAM-HC 1%-1% FOAM 10GM medical supplies. The contract is a Delivery Order under a larger Indefinite Delivery Contract (IDC) with the DLA Troop Support Medical, valued at $999,999,999 and running through November 2026. This IDC serves as a...
This is a $1,853.75 firm fixed-price delivery order awarded to Amerisourcebergen Drug Corp, a major pharmaceutical distributor, by the Defense Logistics Agency (DLA). The contract is for the supply of PROCTOFOAM-HC 1%-1% FOAM 10GM, a medical product, with a completion date of June 26, 2025. The contract is not set-aside. Amerisourcebergen Drug Corp holds a significant $999,999,999.00 Indefinite Delivery Contract (IDC) with the DLA Troop Support Medical, which provides a comprehensive global...
The Defense Logistics Agency (DLA) awarded a firm fixed price delivery order valued at $1,597.45 to Amerisourcebergen Drug Corp, a subsidiary of Amerisourcebergen Corporation, for the supply of PROCTOFOAM-HC 1%-1% FOAM 10GM. This delivery order is part of an indefinite delivery contract (IDC) awarded solely to Amerisourcebergen Drug Corp, with a potential value of $999,999,999.00 and a performance period through December 31, 2025. The IDC serves as the primary contract vehicle for...
This federal contract award was issued by the Defense Logistics Agency (DLA) to Amerisourcebergen Drug Corp, a major pharmaceutical distributor and healthcare solutions provider. The $1,995.40 firm fixed-price delivery order contract covers the supply of PROCTOFOAM-HC 1%-1% FOAM 10GM, a pharmaceutical product. The award is part of a larger $999,999,999 Indefinite Delivery Contract (IDC) held by Amerisourcebergen with the DLA Troop Support Medical. This IDC serves as a primary vehicle for...
This is a $1,643.66 firm fixed-price delivery order awarded to Amerisourcebergen Drug Corp, a major pharmaceutical distributor, by the Defense Logistics Agency (DLA). The contract is for the supply of PROCTOFOAM-HC 1%-1% FOAM 10GM, a pharmaceutical product. The order has a completion date of June 17, 2025. Amerisourcebergen Drug Corp holds a $999,999,999.00 Indefinite Delivery Contract (IDC) with the DLA Troop Support Medical, designated as SPE2DX, which provides a comprehensive global...
The Defense Logistics Agency (DLA) awarded a firm fixed price delivery order contract worth $1,215.60 to Amerisourcebergen Drug Corp, a subsidiary of Amerisourcebergen Corporation, to provide PROCTOFOAM-HC 1%-1% FOAM 10GM. This delivery order contract has a performance period through March 8, 2024 and is not associated with any set-aside designation. Amerisourcebergen Drug Corp is the prime contractor on this award and serves as a key pharmaceutical and medical supplies provider to the...
This federal contract award, valued at $4,814.36, was issued by the Defense Logistics Agency (DLA) to Amerisourcebergen Drug Corp, a major pharmaceutical distributor and healthcare solutions provider. The award is a delivery order contract to provide "PROCTOFOAM-HC 1%-1% FOAM 10GM" medical supplies. The contract has an ultimate completion date of November 26, 2024 and uses a firm fixed price pricing type. Amerisourcebergen holds a significant Indefinite Delivery Contract (IDC) with the...
  • SPE2DB24D2216
    Indefinite Delivery Contract
  • SPE2DB24D2216-SPE2DB25FGMED
    Delivery Order

The Defense Logistics Agency (DLA) awarded a $4,562.04 firm-fixed-price delivery order contract to Amerisourcebergen Drug Corp, a major pharmaceutical distributor, for the supply of PROCTOFOAM-HC 1%-1% FOAM 10GM medical products. This contract is part of a larger $999,999,999 Indefinite Delivery Contract (IDC) held by Amerisourcebergen with DLA Troop Support Medical, which provides a comprehensive range of pharmaceutical and medical supplies to support military healthcare programs globally. The contract has no set-aside designation, indicating open competition. Amerisourcebergen also maintains a separate $750,000 IDC with the Department of Justice Federal Bureau of Investigation for similar medical products and prescription drugs.

Generated 5/20/25, 1:56 PM